Executive Team
Gyrus is managed by investment professionals who share a common investment philosophy and set of values. The team is based in Geneva, Switzerland.
-
Guy Semmens
Partner
-
Dr Robert Watson
Partner
-
Mirco Dilda
Partner
-
Cédric Perlet
Partner
-
Hannah Tobin
Partner
-
Alyson Greenwood
Partner
-
Christian Wipf
Partner
-
Mattias Terribilini
Principal
-
Raffaele Magliocca
Principal
-
Anni Fong
Senior Associate
-
Luigi Dufour
Senior Associate
-
Bianca Bonetti
Associate
-
Lorenz Klein
Associate
Operating and Advisory Partners
-
■ Group Head of Sustainability, Technology Ventures, Kerry Group
■ 30+ years of experience in implementing innovative strategies to transform businesses and operations towards triple-bottom line sustainability
-
■ Vice President International at Fortune 500 Polaris Industries
■ 20+ years of Medical Device & Engineering experience in executive positions across multiple International geographies in private & fortune 50 companies (Stryker)
■ Investor & operating experience in private med-tech holdings
-
■ Chairman, Corcym
■ 30 years of global experience in Medical Device
■ Former President and Executive Officer at Orthofix inc. (NASDAQ, OFIX) and Sorin Heart Valves business
-
■ Former founder and CEO of several consulting companies
■ 40 years top level experience in Management Consulting in Industry, Services and Public Administration
■ Exceptional network in Italy
-
■ CFO and Board Director of Magia Dx
■ Previously a Partner at Argos Wityu, where he worked with Guy for 15 years
■ Prior to Argos, he worked BNP Paribas
-
■ Deputy Chairman, Alvotech; Chairman, Immodulon Therapeutics Ltd
■ Senior Advisor to the Board, CellResearch Corporation
■ Previously President & CEO Auregen Biotherapeutics SA
-
■ Previously COO and CFO of Freemantle Media and before that COO of HIT Entertainment
■ Principal at Apax Partners
■ MBA from Wharton Business School and BS from UC Berkeley
-
■ Previously Founder Partner and Head of Healthcare Investments at HgCapital
■ 24 years of PE experience
■ Advisor to Spring Ventures and EVOCO AG and actively manages a diverse portfolio of other investments.
-
■ Currently Global CIO of SoftwareOne
■ 20+ years in technology services in various industries including med-tech and consumer goods
■ Early stage investor in several tech start-ups
-
■ CEO, Essential Pharma
■ 15+ years of senior level experience in the pharmaceutical industry
■ Previously founder and CFO EUSA Pharma; Head of Partner Markets, Jazz Pharmaceuticals
-
◼︎ Until Dec 2018, UK divisional CFO at IVI, the largest global provider of IVF and related fertility treatments; Founded 2 successful healthcare start-ups in the UK and Australia
◼︎ Previously an investment banker with Houlihan Lokey in Los Angeles, Paris and London
-
◼︎ Former founder and CEO of several consulting companies
◼︎ 40 years of top level experience in Management Consulting in Industry, Services and Public Administration
◼︎ Exceptional network in Italy
-
◼︎ CEO, Corcym and Board Member, Essential Pharma
◼︎ President of Adlon Therapeutics, a commercial stage biotech focused in CNS.
◼︎ Prior to that, he was the Chief Commercial Officer of Mundipharma and a partner at Bain & Co. where he led the UK healthcare practice.
◼︎ MBA from INSEAD, an MD from Sydney University, and a dual BSBA/BA from Boston University
-
◼︎ Currently, manages Alcyon Holding, a family investment company in Switzerland
◼︎ Member of the Board, Invest Europe (the European private equity trade association); member of the Board of Deutsche Bank (Suisse) SA; Chairman of Banque Cantonale du Jura
◼︎ Previously Head of Investor Relations for Europe and the Middle East with KKR. Before that she was a Vice President at HarbourVest Partners in its secondary investment group
-
◼︎ Non-executive chairman of Creo plc, PuriCore plc, IXICO plc and 11 Health and previously Director of Aircraft Medical and Stanmore Implants
◼︎ Previously CEO of MDY Healthcare plc, and head of healthcare corporate finance at both Numis Securities and Nomura International
-
◼︎ Board Member, Corcym
◼︎ 30+ years of experience in medical device regulation and clinical trials with an emphasis on emerging technologies
◼︎ Founder MedPass International, a leading European CRO, regulatory and reimbursement consultancy (acquired by ICON plc in 2020)
-
◼︎ 20 Years in Senior Management in Global regulated Pharmaceuticals corporations (Elan plc, Wyeth, Abbott Laboratories) with special responsibilities for Quality and Regulatory Compliance.
◼︎ Molecular biologist, analytical scientist with extensive experience in quality, compliance and manufacturing due diligence and new product introductions
◼︎ Vice-President Supply Chain and Operations of Class III medical device from start-up, through clinical to full market launch and ramp.
-
◼︎ Board Member, Corcym
◼︎ Founder of Medeor Associates
◼︎ 20+ years of experience in the med-tech sector
◼︎ Previously CEO, Sorin and has served as a board member (often CEO/Chairman) in more than 10 private & listed companies
-
◼︎ CEO of dss+ (formerly DuPont Sustainable Solutions)
◼︎ Prior to dss+, he was global leader of the Sustainability practice at Arthur D. Little
◼︎ Degree in Environmental Engineering from Politecnico di Torino
-
◼︎ 30 years of experience in biotech and pharma industries
◼︎ Previously COO of Cubist, Head of the Global Hospital Business at Mylan Inc. and Head of Global Biopharmaceuticals at Sandoz
◼︎ MD from the University of Leiden